The Lancet Journal
Fecha de publicación: 1 september 2018
DOI: https://doi.org/10.1016/S1474-4422(18)30233-3
Autores: Merel S Ekker, MD. Esther M Boot, MD. Prof Aneesh B Singhal, MD. Prof Kay Sin Tan, FRCP. Prof Stephanie Debette, MD. Anil M Tuladhar, MD. Prof Frank-Erik de Leeuw, MD
Background: Epidemiological evidence suggests that the incidence of ischaemic stroke in young adults (18–50 years) has increased substantially. These patients have a long life expectancy after stroke, and the costs of long-term care pose huge challenges to health-care systems. Although the current recommendations for treatment of young and old (>50 years) patients with stroke are similar, the optimal management of young adult patients with stroke is unknown. They are usually not included in trials, and specific subanalyses limited to young adult patients with stroke are usually not done, owing to lower incidence of stroke and lower prevalence of vascular risk factors in young adults. Progress has been made in identifying patients with a considerable risk of stroke occurrence, such as those with patent foramen ovale. Future prevention studies might result in a decrease in the incidence of stroke and its sequelae in young adults. The development of guidelines specifically devoted to the management of stroke in young adults will be an important step in achieving this aim.
